Publications

Alternative pathways driven by STING: From innate Immunity to lipid metabolism.

Vila IK, Guha S, Kalucka J, Olagnier D, Laguette N.

TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway

Développement et Pathologie de la Gonade

Moïra Rossitto , Stephanie Déjardin , Chris M Rands , Stephanie Le Gras , Roberta Migale , Mahmoud-Reza Rafiee , Yasmine Neirijnck , Alain Pruvost , Anvi Laetitia Nguyen , Guillaume Bossis , Florence Cammas , Lionel Le Gallic , Dagmar Wilhelm , Robin Lovell-Badge , Brigitte Boizet-Bonhoure , Serge Nef , Francis Poulat

en savoir plus

PIWI-Directed DNA Elimination for Tetrahymena Genetics.

Epigenetic Chromatin Regulation

Shehzada S, Mochizuki K

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy.

Modifications épigénétiques et instabilité génomique dans les cellules B normales et tumorales

Laribi K, Baugier de Materre A, Ghez D, Dartigeas C, Tomowiak C, Mahé B, Micol JB, Merabet F, Leprêtre S, Herbaux C, Ysebaert L, Le Calloch R, Willems L, Voldoire M, Roos-Weil D, Bravetti C, Touileb Y, Davi F, Nguyen-Khac F, Maloum K, Béné MC

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL.

IMGT® - le système d'information international en ImMunoGénéTique

Agathangelidis A, Chatzidimitriou A, Chatzikonstantinou T, Tresoldi C, Davis Z, Giudicelli V, Kossida S, Belessi C, Rosenquist R, Ghia P, Langerak AW, Davi F, Stamatopoulos K, ERIC: the European Research Initiative on CLL

Protocol to induce and assess cGAS-STING pathway activation in vitro.

Chamma H, Guha S, Laguette N, Vila IK

Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity

Hanane Chamma, Isabelle K Vila, Clara Taffoni, Andrei Turtoi, Nadine Laguette

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).

Modifications épigénétiques et instabilité génomique dans les cellules B normales et tumorales

Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R, Lymphoma Study Association (LYSA)